Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir Fa- Da Wang; Jing Zhou; Lan-Qing Li; Yu-Jing Li; Meng-Lan Wang; Ya-Chao Tao; Dong-Mei Zhang; Yong-Hong Wang; En-Qiang Chen;

Trends and health inequalities of hepatitis virus-associated liver cancer mortality during 1990¿2050 Yujiao Deng; Jingyue Tan; Jian Zu; Zixuan Xing; Zhanpeng Yang; Yue Zhang; Yajing Bo; Xu Gao; Enrui Xie; Yuan Wang; Meijuan Han; Fanpu Ji; Yang Yang;

Reevaluating the clinical course of AMA-positive patients with normal liver enzymes: A large retrospective cohort study Ahmad Yahia; Fadi Abu Baker; Mifleh Tatour; Rawi Hazzan;